Women suffering from epilepsy require special attention throughout their life. In this review, management of epilepsy during the periods of perimenopause, menopause and late maturity is discussed. The effect of epilepsy on age at menopause, changes in seizure frequency during perimenopause and menopause, and the risks of hormone replacement therapy are also presented. Altered antiepileptic drug pharmacokinetics with increasing age and the management of this vulnerable population is also discussed.
HardenCL, KoppelBS, HerzogAG, NikolovBG, HauserWA. Seizure frequency is associated with age of menopause in women with epilepsyNeurology2003; 61: 451-5
2.
AbbasiF, KrumholzA, KittnerSJ, LangenbergP. Effects of menopause on seizures in women with epilepsy. Epilepsia1999; 40: 205-10
3.
HardenCL, PulverMC, RavdinL, JacobsAR. The effects of menopause and perimenopause on the course of epilepsy. Epilepsia1999; 40: 1402-7
4.
HardenCL, HerzogAG, NikolovBGHormone replacement therapy in women with epilepsy: a randomized, double-blind, placebo-controlled study. Epilepsia2006; 47: 1447-51
5.
RossouwJE, AndersonGL, PrenticeRLRisks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA2002; 288: 321-33
6.
EnsrudKE, WalczakTS, BlackwellT, EnsrudER, BowmanPJ, StoneKL. Antiepileptic drug use increases rates of bone loss in older women: a prospective study. Neurology2004; 62: 2051-7
7.
PackAM, MorrellMJ. Epilepsy and bone health in adults. Epilepsy Behav2004; 5 (suppl. 2): S24-9
8.
ShethRD, WesolowskiCA, JacobJCEffect of carbamazepine and valproate on bone mineral density. J Pediatr1995; 127: 256-62
9.
GidalBE. Antiepileptic drug formulation and treatment in the elderly: biopharmaceutical considerations. Int Rev Neurobiol2007; 81: 299-311
